Shannon Reaney is the chair of the firm’s Patent Strategy + Prosecution Group and co-chair of the cross-disciplinary Intellectual Property Group. As a seasoned patent attorney, she provides strategic counsel to life sciences companies, specializing in developing and managing global patent portfolios.

With over 20 years of experience, Shannon excels in IP strategy for a wide range of life sciences technologies, including pre-clinical and clinical stage therapeutics, drug delivery systems and diagnostics. She has worked on numerous patent portfolios related to approved drugs and has helped innovator companies secure valuable patent term extension for a variety of approved drugs and biologics. Shannon has particular experience with small-molecule pharmaceuticals, siRNA therapeutics, peptide therapeutics, blood-based therapies, conjugates, pharmaceutical forms and formulations as well as agricultural technologies and materials.

Shannon is a leading lawyer in building and strengthening patent portfolios for mid-size to large companies and assisting startups in securing foundational intellectual property. She has extensive experience with pre-litigation portfolio assessments, strategies to protect late-stage and approved products, mitigating invalidity risks, non-infringement positions, and obtaining patent term extensions.

As a member of the firm’s Venture Intellectual Property Group, Shannon has conducted numerous due diligence evaluations for investors in the life sciences sector, enhancing her ability to assist clients with strategic positioning for financing or other transactions.

She received her Ph.D. in chemistry from the University of California, Santa Cruz, where her doctoral research concentrated on synthetic organic methodology and the use of lithium aminoborohydrides in novel hydride and amine transfer reactions. Shannon has published several first-author papers in peer-reviewed journals and has presented her research at numerous conferences, including those sponsored by the American Chemical Society and the IUPAC World Chemistry Congress. She received her B.A. in biochemistry from Occidental College, where she conducted undergraduate research investigating psoralen-DNA intercalation.